Accessibility Menu
OrthoPediatrics Stock Quote

OrthoPediatrics (NASDAQ: KIDS)

$17.88
(-0.1%)
-0.03
Price as of October 22, 2025, 4:00 p.m. ET

KEY DATA POINTS

Current Price
$17.88
Daily Change
(-0.1%) $0.03
Day's Range
$17.23 - $18.15
Previous Close
$17.88
Open
$17.88
Beta
1.21
Volume
312,554
Average Volume
176,542
Market Cap
448.9M
Market Cap / Employee
$17.90M
52wk Range
$15.28 - $32
Revenue
-
Gross Margin
0.63%
Dividend Yield
N/A
EPS
-$1.8
CAPs Rating
-
Industry
Healthcare Equipment and Supplies

The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More

OrthoPediatrics Return vs. S&P

1 Year5 Year5 Year AnnualizedSince IPO
KIDS-32.93%-63.53%-18.27%-7%
S&P+15.06%+95.03%+14.29%+164%

OrthoPediatrics Company Info

OrthoPediatrics Corp. is an orthopedic company, which engages in the design, development, and marketing of anatomically appropriate implants and devices for children with orthopedic conditions. It offers products relating to trauma and deformity, scoliosis, and sports medicine and other procedures. The company was founded by Erin Springer Yount and Nick A. Deeter in August 2006 and is headquartered in Warsaw, IN.

News & Analysis

Financial Health

General

Q2 2025YOY Change
Revenue$61.08M15.7%
Gross Profit$38.85M7.9%
Gross Margin63.60%-4.6%
Market Cap$532.04M-22.4%
Market Cap / Employee$0.95M0.0%
Employees562127.5%
Net Income-$7.11M-18.0%
EBITDA-$2.52M-183.7%

Currently no data to display

Revenue Growth Rate

Currently no data to display.

Earnings Per Share Growth Rate

Currently no data to display.

Assets

Q2 2025YOY Change
Net Cash$46.61M50.9%
Accounts Receivable$53.80M28.0%
Inventory125.37.6%

Liabilities

Q2 2025YOY Change
Long Term Debt$97.23M700.0%
Short Term Debt$0.77M-47.0%

Ratios

Q2 2025YOY Change
Return On Assets-8.94%-3.1%
Return On Invested Capital-6.74%-0.2%

Cash Flow

Q2 2025YOY Change
Free Cash Flow-$13.91M-6.0%
Operating Free Cash Flow-$10.46M-62.6%

Valuation

MetricQ3 2024Q4 2024Q1 2025Q2 2025YoY Change
Price to Book1.771.511.681.54-15.91%
Price to Sales3.312.622.692.28-39.96%
Price to Tangible Book Value3.372.883.323.06-14.21%
Enterprise Value to EBITDA-2190.63-120.50-99.86-210.54-71.20%
Return on Equity-7.6%-10.3%-11.3%-11.5%71.94%
Total Debt$76.41M$84.70M$77.05M$98.00M619.91%

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.